🚀 VC round data is live in beta, check it out!
NIOX Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for NIOX Group and similar public comparables like Carlsmed, Asterasys, Universal Vision, Senseonics Holdings and more.
NIOX Group Overview
About NIOX Group
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
Founded
2006
HQ
Employees
91
Website
Financials (LTM)
EV
$340M
NIOX Group Financials
NIOX Group reported last 12-month revenue of $66M and EBITDA of $23M.
In the same LTM period, NIOX Group generated $23M in EBITDA and $11M in net income.
Revenue (LTM)
NIOX Group P&L
In the most recent fiscal year, NIOX Group reported revenue of $65M and EBITDA of $22M.
NIOX Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $66M | XXX | $65M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $45M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 68% | XXX | XXX | XXX |
| EBITDA | $23M | XXX | $22M | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 34% | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 22% | XXX | XXX | XXX |
| Net Profit | $11M | XXX | $9M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 14% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
NIOX Group Stock Performance
NIOX Group has current market cap of $354M, and enterprise value of $340M.
Market Cap Evolution
NIOX Group's stock price is $0.85.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $340M | $354M | 0.4% | XXX | XXX | XXX | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNIOX Group Valuation Multiples
NIOX Group trades at 5.2x EV/Revenue multiple, and 15.1x EV/EBITDA.
EV / Revenue (LTM)
NIOX Group Financial Valuation Multiples
As of April 8, 2026, NIOX Group has market cap of $354M and EV of $340M.
Equity research analysts estimate NIOX Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
NIOX Group has a P/E ratio of 31.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $354M | XXX | $354M | XXX | XXX | XXX |
| EV (current) | $340M | XXX | $340M | XXX | XXX | XXX |
| EV/Revenue | 5.2x | XXX | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | 15.1x | XXX | 15.2x | XXX | XXX | XXX |
| EV/EBIT | 22.6x | XXX | 23.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 7.6x | XXX | XXX | XXX |
| P/E | 31.7x | XXX | 37.8x | XXX | XXX | XXX |
| EV/FCF | 16.7x | XXX | 16.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NIOX Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
NIOX Group Margins & Growth Rates
NIOX Group's revenue in the last 12 month grew by 4%.
NIOX Group's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.
NIOX Group's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
NIOX Group's rule of X is 44% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
NIOX Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 34% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 23% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 18% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
NIOX Group Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Carlsmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Asterasys | XXX | XXX | XXX | XXX | XXX | XXX |
| Universal Vision | XXX | XXX | XXX | XXX | XXX | XXX |
| Senseonics Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| VieMed | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NIOX Group M&A Activity
NIOX Group acquired XXX companies to date.
Last acquisition by NIOX Group was on XXXXXXXX, XXXXX. NIOX Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by NIOX Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNIOX Group Investment Activity
NIOX Group invested in XXX companies to date.
NIOX Group made its latest investment on XXXXXXXX, XXXXX. NIOX Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by NIOX Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NIOX Group
| When was NIOX Group founded? | NIOX Group was founded in 2006. |
| Where is NIOX Group headquartered? | NIOX Group is headquartered in United Kingdom. |
| How many employees does NIOX Group have? | As of today, NIOX Group has over 91 employees. |
| Who is the CEO of NIOX Group? | NIOX Group's CEO is Jonathan Charles Emms. |
| Is NIOX Group publicly listed? | Yes, NIOX Group is a public company listed on London Stock Exchange. |
| What is the stock symbol of NIOX Group? | NIOX Group trades under NIOX ticker. |
| When did NIOX Group go public? | NIOX Group went public in 2014. |
| Who are competitors of NIOX Group? | NIOX Group main competitors are Carlsmed, Asterasys, Universal Vision, Senseonics Holdings. |
| What is the current market cap of NIOX Group? | NIOX Group's current market cap is $354M. |
| What is the current revenue of NIOX Group? | NIOX Group's last 12 months revenue is $66M. |
| What is the current revenue growth of NIOX Group? | NIOX Group revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of NIOX Group? | Current revenue multiple of NIOX Group is 5.2x. |
| Is NIOX Group profitable? | Yes, NIOX Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of NIOX Group? | NIOX Group's last 12 months EBITDA is $23M. |
| What is NIOX Group's EBITDA margin? | NIOX Group's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of NIOX Group? | Current EBITDA multiple of NIOX Group is 15.1x. |
| What is the current FCF of NIOX Group? | NIOX Group's last 12 months FCF is $20M. |
| What is NIOX Group's FCF margin? | NIOX Group's last 12 months FCF margin is 31%. |
| What is the current EV/FCF multiple of NIOX Group? | Current FCF multiple of NIOX Group is 16.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.